Literature DB >> 2166835

T-cell activation is required for efficient replication of human herpesvirus 6.

N Frenkel1, E C Schirmer, G Katsafanas, C H June.   

Abstract

We have investigated whether T-cell activation is required for the replication of the T-lymphotropic human herpesvirus 6. The virus did not replicate in quiescent peripheral blood lymphocytes but replicated efficiently following exposure of the cells to the polyclonal mitogen phytohemagglutinin (PHA). When purified T cells were treated with PHA in the absence of accessory cells, no virus replication was observed unless exogenous interleukin-2 (IL-2) was added to the medium, promoting cell division. Incubation of peripheral blood lymphocytes in the absence of PHA but in the presence of IL-2 resulted in delayed cell blastogenesis and virus replication. Cell blastogenesis and virus replication did not occur in the purified T-cell cultures incubated with IL-2 alone. Taken together, the results show that human herpesvirus 6 replication requires full progression of the cell cycle. This finding might have implications for the pathogenicity of the virus in the human host.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166835      PMCID: PMC247937          DOI: 10.1128/JVI.64.9.4598-4602.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Evidence that T cell activation is required for HIV-1 entry in CD4+ lymphocytes.

Authors:  S D Gowda; B S Stein; N Mohagheghpour; C J Benike; E G Engleman
Journal:  J Immunol       Date:  1989-02-01       Impact factor: 5.422

2.  Clinical and serological features of human herpesvirus-6 infection in three adults.

Authors:  J C Niederman; C R Liu; M H Kaplan; N A Brown
Journal:  Lancet       Date:  1988-10-08       Impact factor: 79.321

3.  New T-lymphotropic human herpesviruses.

Authors:  W B Becker; S Engelbrecht; M L Becker; C Piek; B A Robson; L Wood; P Jacobs
Journal:  Lancet       Date:  1989-01-07       Impact factor: 79.321

4.  Transactivation of human immunodeficiency virus promoter by human herpesvirus 6.

Authors:  R T Horvat; C Wood; N Balachandran
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

5.  Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6.

Authors:  P Lusso; B Ensoli; P D Markham; D V Ablashi; S Z Salahuddin; E Tschachler; F Wong-Staal; R C Gallo
Journal:  Nature       Date:  1989-01-26       Impact factor: 49.962

6.  Exanthem subitum and antibody to human herpesvirus-6.

Authors:  K Ueda; K Kusuhara; M Hirose; K Okada; C Miyazaki; K Tokugawa; M Nakayama; K Yamanishi
Journal:  J Infect Dis       Date:  1989-04       Impact factor: 5.226

7.  Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6).

Authors:  D V Ablashi; P Lusso; C L Hung; S Z Salahuddin; S F Josephs; T Llana; B Kramarsky; P Biberfeld; P D Markham; R C Gallo
Journal:  Int J Cancer       Date:  1988-11-15       Impact factor: 7.396

8.  Antibody reactivity with HBLV (HHV-6) in U.S. populations.

Authors:  C Saxinger; H Polesky; N Eby; S Grufferman; R Murphy; G Tegtmeir; V Parekh; S Memon; C Hung
Journal:  J Virol Methods       Date:  1988-09       Impact factor: 2.014

9.  Seroepidemiology of human herpesvirus 6 infection in normal children and adults.

Authors:  T Okuno; K Takahashi; K Balachandra; K Shiraki; K Yamanishi; M Takahashi; K Baba
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

10.  Polymerase chain reaction amplification and in situ hybridization for the detection of human B-lymphotropic virus.

Authors:  A Buchbinder; S F Josephs; D Ablashi; S Z Salahuddin; M E Klotman; M Manak; G R Krueger; F Wong-Staal; R C Gallo
Journal:  J Virol Methods       Date:  1988-09       Impact factor: 2.014

View more
  12 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Pneumonitis associated with coinfection by human herpesvirus 6 and Legionella in an immunocompetent adult.

Authors:  S K Russler; M A Tapper; K K Knox; A Liepins; D R Carrigan
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

3.  Toward synthetic biology with engineered T cells: a long journey just begun.

Authors:  Carl H June
Journal:  Hum Gene Ther       Date:  2014-09       Impact factor: 5.695

4.  Tropism of varicella-zoster virus for human tonsillar CD4(+) T lymphocytes that express activation, memory, and skin homing markers.

Authors:  Chia-Chi Ku; Jorge A Padilla; Charles Grose; Eugene C Butcher; Ann M Arvin
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

5.  The DR1 and DR6 first exons of human herpesvirus 6A are not required for virus replication in culture and are deleted in virus stocks that replicate well in T-cell lines.

Authors:  Ronen Borenstein; Haim Zeigerman; Niza Frenkel
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

6.  Use of amplicon-6 vectors derived from human herpesvirus 6 for efficient expression of membrane-associated and -secreted proteins in T cells.

Authors:  Ronen Borenstein; Oded Singer; Adi Moseri; Niza Frenkel
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  Infection and immunoregulation of T lymphocytes by parainfluenza virus type 3.

Authors:  S Sieg; C Muro-Cacho; S Robertson; Y Huang; D Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

8.  In vitro activation of human herpesviruses 6 and 7 from latency.

Authors:  G C Katsafanas; E C Schirmer; L S Wyatt; N Frenkel
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

9.  Restriction endonuclease mapping and molecular cloning of the human herpesvirus 6 variant B strain Z29 genome.

Authors:  G J Lindquester; N Inoue; R D Allen; J W Castelli; F R Stamey; T R Dambaugh; J J O'Brian; R M Danovich; N Frenkel; P E Pellett
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

10.  Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15.

Authors:  L Flamand; I Stefanescu; J Menezes
Journal:  J Clin Invest       Date:  1996-03-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.